Axogen AXGN
NASDAQ AXGN
$45.58 -3.35 (-6.84%)
At close: Aug 20, 2026 · 2:20 PM UTC

Axogen (AXGN) Deferred Taxes (2016 - 2017)

Axogen (AXGN) posted quarterly Deferred Taxes of -$29051.0 for Q4 2017, down 345.05% year-over-year from $11855.0 in Q4 2016, and down 449.17% quarter-over-quarter from -$5290.0 in Q3 2017.

Axogen (AXGN) Deferred Taxes (2016 - 2017) Analysis & Trends

Axogen's Deferred Taxes history runs 2 years deep, the most recent figure standing at -$29051.0 for Q4 2017.

  • In Q4 2017, Deferred Taxes fell 345.05% year-over-year to -$29051.0; the TTM figure through Dec 2017 stood at -$20443.0 (changed N/A YoY), while the FY2017 annual figure was $70316.0, up 299.93% from the prior year.
  • Deferred Taxes for Q4 2017 stood at -$29051.0, down from -$5290.0 in the prior quarter.
  • The five-year high for Deferred Taxes was $11855.0 in Q4 2016, with the low at -$29051.0 in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Abbott Laboratories 199.49 Bn 193.88 Bn 7.27 Bn -
2 Stryker 127.80 Bn 124.32 Bn 4.50 Bn 107.00 Mn
3 Medtronic 118.98 Bn 109.76 Bn 6.41 Bn -8.00 Mn
4 Boston Scientific 73.58 Bn 73.04 Bn 3.85 Bn 17.00 Mn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn -181.30 Mn
6 Dexcom 34.34 Bn 32.39 Bn 830.00 Mn -300,000.00
7 GE HealthCare Technologies 33.76 Bn 31.66 Bn 2.18 Bn -
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn 235.96 Mn
9 Steris 23.07 Bn 22.59 Bn 684.20 Mn 600,000.00
10 Axogen 2.42 Bn 2.31 Bn 50.67 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2017 -29,051.00
Sep 30, 2017 -5,290.00
Dec 31, 2016 11,855.00
Sep 30, 2016 2,043.00